Guidelines for the investigation of chronic diarrhoea, 2nd edition

Gut

Volumn 52, Issue SUPPL. 5, 2003, Pages

  Thomas, P D ^a   Forbes, A ^b   Green, J ^c   Howdle, P ^d   Long, R ^e   Playford, R ^f   Sheridan, M ^d   Stevens, R ^g   Valori, R ^h   Walters, J ^f   Addison, G M ⁱ   Hill, P ^j   Brydon, G ^k  

^a MUSGRAVE PARK HOSPITAL   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

^c LLANDOUGH HOSPITAL   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

^g East Oxford Health Centre   (United Kingdom)

^h GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

ⁱ ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^j HOPE HOSPITAL   (United Kingdom)

^k WESTERN GENERAL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BILE SALT; C REACTIVE PROTEIN; CARBON 14; COLESTYRAMINE; ELECTROLYTE; ENDOMYSIUM ANTIBODY; ENZYME; FAT; HORMONE; LACTOSE; SELENIUM 75; TRIACYLGLYCEROL; UREA; XYLOSE;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ANAMNESIS; ASPIRATION; BACTERIAL OVERGROWTH; BLOOD ANALYSIS; BLOOD CELL COUNT; BREATH ANALYSIS; CARBOHYDRATE ANALYSIS; CELIAC DISEASE; CHRONIC DIARRHEA; CLINICAL FEATURE; COLON MUCOSA; COLONOSCOPY; CONCENTRATION (PARAMETERS); EMPIRICISM; ENDOSCOPY; ENTEROPATHY; ENTEROSCOPY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FACTITIOUS DISEASE; FECES; FECES ANALYSIS; FECES CULTURE; HISTOLOGY; HORMONE RELEASE; HUMAN; IMAGING; IMMUNOCOMPETENCE; INTESTINE TRANSIT TIME; LACTOSE INTOLERANCE; LARGE INTESTINE; LIPID ABSORPTION; LIPID ANALYSIS; LIVER FUNCTION TEST; MALABSORPTION; MEDICAL AUDIT; MEDICAL EXAMINATION; NOMENCLATURE; PANCREAS FUNCTION TEST; PANCREAS INSUFFICIENCY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SEROLOGY; SIGMOIDOSCOPY; SMALL INTESTINE MUCOSA; TUMOR; URINALYSIS; VALIDATION PROCESS;

BARIUM SULFATE; CHRONIC DISEASE; DIARRHEA; ENDOSCOPY, GASTROINTESTINAL; ENEMA; EXOCRINE PANCREATIC INSUFFICIENCY; FACTITIOUS DISORDERS; HUMANS; MALABSORPTION SYNDROMES; MEDICAL HISTORY TAKING; NEOPLASMS; PHYSICAL EXAMINATION;

EID: 17044458998     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (213)

1. Wenzl HH, Fine KD, Schiller LR, et al. Determinants of decreased fecal consistency in patients with diarrhea. Gastroenterology 1995;108:1729-38.
2. Schiller LR, Hogan RB, Morawski SG, et al. Studies of the prevalence and significance of radiolabeled bile acid malabsorption in a group of patients with idiopathic chronic diarrhea. Gastroenterology 1987;92:151-60.
3. Madoff RD, Williams JG, Caushaj PF. Fecal incontinence. N Engl J Med 1992;326:1002-7.
4. Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999;116:1464-86.
5. Talley NJ, O'Keefe EA, Zinsmeister AR, et al. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992;102:895-901.
6. Talley NJ, Weaver AL, Zinsmeister AR, et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165-77.
7. Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. BMJ 1978;2:653-54.
8. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(suppl 2):II43-7.
9. Jones J, Boorman J, Cann P, et al. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000;47(suppl 2):ii1-19.
10. Duncan A, Hill PG. AUK survey of laboratory-based gastrointestinal investigations. Ann Clin Biochem 1998;35:492-503.
11. Talley NJ, Phillips SF, Melton LJ, et al. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990;31:77-81.
12. Bytzer P, Stokholm M, Andersen II, et al. Aetiology, medical history, and faecal weight in adult patients referred for diarrhoea. A prospective survey. Scand J Gastroenterol 1990;25:572-8.
13. Bertomeu A, Ros E, Barragán V, et al. Chronic diarrhea with normal stool and colonic examinations: organic or functional? J Clin Gastroenterol 1991;13:531-6.
14. Isgar B, Harman M, Kaye MD, et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983;24:190-2.
15. Thompson WG. Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease. Gut 1984;25:1089-92.
16. Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994;89:176-8.
17. Arrambide KA, Santa A, Schiller LR, et al. Loss of absorptive capacity for sodium chloride as a cause of diarrhea following partial ileal and right colon resection. Dig Dis Sci 1989;34:193-201.
18. Ros E, Zambon D. Postcholecystectomy symptoms. A prospective study of gall stone patients before and two years after surgery. Gut 1987;28:1500-4.
19. Suhr O, Danielsson A, Nyhlin H, et al. Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand J Gastroenterol 1988;23:1187-94.
20. Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc 1993;68:691-702.
21. Persson J. Alcohol and the small intestine. Scand J Gastroenterol 1991;26:3-15.
22. Join NK, Rosenberg DB, Ulahannan MJ, et al. Sorbitol intolerance in adults. Am J Gastroenterol 1985;80:678-81.
23. Read NW, Krejs GJ, Read MG, et al. Chronic diarrhea of unknown origin. Gastroenterology 1980;78:264-71.
24. Ackerman Z, Eliakim R, Stalnikowicz R, et al. Role of small bowel biopsy in the endoscopic evaluation of adults with iron deficiency anemia. Am J Gastroenterol 1996;91:2099-102.
25. Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology. Gut 2000;46(suppl 3-4):IV1-5.
26. Corazza GR, Andreani ML, Biagi F, et al. The smaller size of the 'coeliac iceberg' in adults. Scand J Gastroenterol 1997;32:917-19.
27. Collin P, Reunala T, Rasmussen M, et al. High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol 1997;32:1129-33.
28. Not T, Horvath K, Hill ID, et al. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998;33:494-8.
29. Ascher H, Kristiansson B. The highest incidence of celiac disease in Europe: the Swedish experience. J Pediatr Gastroenterol Nutr 1997;24:S3-6
30. Catassi C, Ratsch IM, Fabiani E, et al. High prevalence of undiagnosed coeliac disease in 5280 Italian students screened by antigliadin antibodies. Acta Paediatr 1995;84:672-6.
31. Jansson U, Johansson C. Down syndrome and celiac disease. J Pediatr Gastroenterol Nutr 1995;21:443-5.
32. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801.
33. Sugai E, Selvaggio G, Vazquez H, et al. Tissue transglutaminase antibodies in celiac disease: assessment of a commercial kit. Am J Gastroenterol 2000;95:2318-22.
34. Malberg K, Malfertheiner P, Bannert N, et al. IgA-tissue transglutaminase (tTG)- antibodies are highly sensitive serum markers for celiac disease. Am J Gastroenterol 1999;94:3079-80.
35. Biagi F, Ellis HJ, Yiannakou JY, et al. Tissue transglutaminase antibodies in celiac disease. Am J Gastroenterol 1999;94:2187-92.
36. Sardy M, Odenthal U, Karpati S, et al. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 1999;45:2142-9.
37. Sardy M, Karpati S, Peterfy F, et al. Comparison of a tissue transglutaminase ELISA with the endomysium antibody test in the diagnosis of gluten-sensitive enteropathy. Z Gastroenterol 2000;38:357-64.
38. Dahele A, Kingstone K, Bode J, et al. Anti-endomysial antibody negative celiac disease: does additional serological testing help? Dig Dis Sci 2001;46:214-21.
39. Collin P, Maki M, Keyrilainen O, et al. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol 1992;27:367-71.
40. Cataldo F, Marino V, Bottaro G, et al. Celiac disease and selective immunoglobulin A deficiency. J Pediatr 1997;131:306-8.
41. Cataldo F, Marino V, Ventura A, et al. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and "Club del Tenue" Working Groups on Coeliac Disease. Gut 1998;42:362-5.
42. Cataldo F, Lio D, Marino V, et al. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue. Gut 2000;47:366-9.
43. Binder HJ. The gastroenterologist's osmotic gap: fact or fiction? Gastroenterology 1992;103:702-4.
44. Eherer AJ, Fordtran JS. Fecal osmotic gap and pH in experimental diarrhea of various causes. Gastroenterology 1992;103:545-51.
45. Isaac-Renton JL. Laboratory diagnosis of giardiasis. Clin Lab Med 1991;11:811-27.
46. Rosenblatt JE, Sloan LM, et al. Evaluation of an enzyme-linked immunosorbent assay for the detection of Giardia lamblia in stool specimens. Diagn Microbiol Infect Dis 1993;16:337-41.
47. Monk TG, Zaat JO, Deelder AM, et al. Sensitivity of microscopy versus enzyme immunoassay in the laboratory diagnosis of giardiasis. Eur J Clin Microbiol Infect Dis 1997;16:615-19.
48. Markell E, Voge M, John D. Medical Parasitology. In: Markell E, Voge M, John D, eds. Medical Parasitology, 7th edn. Philadelphia: WB Saunders, 1992.
49. Sugi K, Saitoh O, Hirata I, et al. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol 1996;91:927-34.
50. Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15-22.
51. Limburg P, Ahlquist D, Sandborn W, et al. Fecal calprotectin levels predict colorectal inflammation amoung patients with chronic diarrhoea referred for colonoscopy. Am J Gastroenterol 2000;95:2831-7.
52. Duncan A, Morris AJ, Cameron A, et al. Laxative induced diarrhoea - a neglected diagnosis. J R Soc Med 1992;85:203-5.
53. Neims DM, McNeill J, Giles TR, et al. Incidence of laxative abuse in community and bulimic populations: a descriptive review. Int J Eat Disord 1995;17:211-28.
54. Weltzin TE, Bulik CM, McConaha CW, et al. Laxative withdrawal and anxiety in bulimia nervosa. Int J Eat Disord 1995;17:141-6.
55. Ladefoged K, Schaffalitzky dM, Jarnum S. Faecal osmolality and electrolyte concentrations in chronic diarrhoea: do they provide diagnostic clues? Scand J Gastroenterol 1987;22:813-20.
56. Topazian M, Binder HJ. Brief report: factitious diarrhea detected by measurement of stool osmolality. N Engl J Med 1994;330:1418-19.
57. Duncan A, Cameron A, Stewart MJ, et al. Diagnosis of the abuse of magnesium and stimulant laxatives. Ann Clin Biochem 1991;28:568-73.
58. Perkins SL, Livesey JF. A rapid high-performance thin-layer chromatographic urine screen for laxative abuse. Clin Biochem 1993;26:179-81.
59. de Wolff FA, Edelbroek PM, de Haas EJ, et al. Experience with a screening method for laxative abuse. Hum Toxicol 1983;2:385-9.
60. Plumeri PA. The room search. J Clin Gastroenterol 1984;6:181-5.
61. Marshall JB, Singh R, Diaz-Arias AA. Chronic, unexplained diarrhea: are biopsies necessary if colonoscopy is normal? Am J Gastroenterol 1995;90:372-6.
62. Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc 2000;51:318-26.
63. Guillem JG, Forde KA, Treat MR, et al. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study. Dis Colon Rectum 1992;35:523-9.
64. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-8.
65. Bazzoli F, Fossi S, Sottili S, et al. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology 1995;109:783-8.
66. Hunt LM, Rooney PS, Hardcastle JD, et al. Endoscopic screening of relatives of patients with colorectal cancer. Gut 1998;42:71-5.
67. Neugut AI, Garbowski GC, Waye JD, et al. Diagnostic yield of colorectal neoplasia with colonoscopy for abdominal pain, change in bowel habits, and rectal bleeding. Am J Gastroenterol 1993;88:1179-83.
68. Patel Y, Pettigrew NM, Grahame GR, et al. The diagnostic yield of lower endoscopy plus biopsy in nonbloody diarrhea. Gastrointest Endosc 1997;46:338-43.
69. Lee JH, Rhee PL, Kim JJ, et al. The role of mucosal biopsy in the diagnosis of chronic diarrhea: value of multiple biopsies when colonoscopic finding is normal or nonspecific. Korean J Intern Med 1997;12:182-7.
70. Shah RJ, Fenoglio P, Bleau BL, et al. Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea. Am J Gastroenterol 2001;96:1091-5.
71. Zwas FR, Bonheim NA, Berken CA, et al. Diagnostic yield of routine ileoscopy. Am J Gastroenterol 1995;90:1441-3.
72. Geboes K, Ectors N, D'Haens G, et al. Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease? Am J Gastroenterol 1998;93:201-6.
73. Mullhaupt B, Guller U, Anabitarte M, et al. Lymphocytic colitis: clinical presentation and long term course. Gut 1998;43:629-33.
74. Baert F, Wouters K, Haens G, et al. Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut 1999;45:375-81.
75. Offner FA, Jao RV, Lewin KJ, et al. Collagenous colitis: a study of the distribution of morphological abnormalities and their histological detection. Hum Pathol 1999;30:451-7.
76. FernandezBanares F, Salas A, Forne M, et al. Incidence of collagenous and lymphacytic colitis: a 5-year population-based study. Am J Gastroenterol 1999;94:418-23.
77. Rex DK, Rahmani EY, Haseman JH, et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997;112:17-23.
78. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double- contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 2000;342:1766-72.
79. Rosenbusch G, Jansen JB, Reeders JW. Contemporary radiological examination of the small bowel. Baillieres Clin Gastroenterol 1994;8:683-700.
80. Barloon TJ, Lu CC, Honda H, et al. Does a normal small-bowel enteroclysis exclude small-bowel disease? A long-term follow-up of consecutive normal studies. Abdom Imaging 1994;19:113-15.
81. Bernstein CN, Boult IF, Greenberg HM, et al. A prospective randomized comparison between small bowel enteroclysis and small bowel follow-through in Crohn's disease. Gastroenterology 1997;113:390-8.
82. Nolan DJ, Traill ZC. The current role of the barium examination of the small intestine. Clin Radiol 1997;52:809-20.
83. Bouhnik Y, Bitoun A, Coffin B, et al. Two way push videoenteroscopy in investigation of small bowel disease. Gut 1998;43:280-4.
84. Landi B, Tkoub M, Gaudric M, et al. Diagnostic yield of push-type enteroscopy in relation to indication. Gut 1998;42:421-5.
85. Segal AW, Ensell J, Munro JM, et al. Indium- 111 tagged leucocytes in the diagnosis of inflammatory bowel disease. Lancet 1981;2:230-2.
86. Gibson P, Lichtenstein M, Salehi N, et al. Value of positive technetium-99m leucocyte scans in predicting intestinal inflammation. Gut 1991;32:1502-7.
87. Kennan N, Hayward M. Tc HMPAO-labelled white cell scintigraphy in Crohn's disease of the small bowel. Clin Radiol 1992;45:331-4.
88. Fine KD, Fordtran JS. The effect of diarrhea on fecal fat excretion. Gastroenterology 1992;102:1936-9.
89. Hill P. Faecal fat: time to give it up. Ann Clin Biochem 2001;38:164-7.
90. Bo-Linn GW, Fordtran JS. Fecal fat concentration in patients with steatorrhea. Gastroenterology 1984;87:319-22.
91. Roberts IM, Poturich C, Wald A. Utility of fecal fat concentrations as screening test in pancreatic insufficiency. Dig Dis Sci 1986;31:1021-4.
92. Lembcke B, Grimm K, Lankisch PG. Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea. Am J Gastroenterol 1987;82:526-31.
93. Bai JC, Andrush A, Matelo G, et al. Fecal fat concentration in the differential diagnosis of steatorrhea. Am J Gastroenterol 1989;84:27-30.
94. Benini L, Caliari S, Bonfante F, et al. Fecal fat concentration in the screening of steatorrhea. Digestion 1992;53:94-100.
95. Ventrucci M, Cipolla A, Di Stefano M, et al. Determination of fecal fat concentration by near infrared spectrometry for the screening of pancreatic steatorrhea. Int J Pancreatol 1998;23:17-23.
96. Amann ST, Josephson SA, Toskes PP. Acid steatocrit: a simple, rapid gravimetric method to determine steatorrhea. Am J Gastroenterol 1997;92:2280-4.
97. Fine KD, Ogunji F. A new method of quantitative fecal fat microscopy and its correlation with chemically measured fecal fat output. Am J Clin Pathol 2000;113:528-34.
98. Nakamura T, Takeuchi T. Pancreatic steatorrhea, malabsorption, and nutrition biochemistry: a comparison of Japanese, European, and American patients with chronic pancreatitis. Pancreas 1997;14:323-33.
99. Turner JM, Lawrence S, Fellows IW, et al. [14C]-triolein absorption: a useful test in the diagnosis of malabsorption. Gut 1987;28:694-700.
100. Duncan A, Cameron A, Stewart MJ, et al. Limitations of the triolein breath test. Clin Chim Acta 1992;205:51-64.
101. Einarsson K, Bjorkhem I, Eklof R, et al. 14C-triolein breath test as a rapid and convenient screening test for fat malabsorption. Scand J Gastroenterol 1983;18:9-12.
102. Benini L, Scuro LA, Menini E, et al. Is the 14C-triolein breath test useful in the assessment of malabsorption in clinical practice? Digestion 1984;29:91-7.
103. Lembcke B, Braden B, Caspary WF. Exocrine pancreatic insufficiency: accuracy and clinical value of the uniformly labelled 13C-Hiolein breath test. Gut 1996;39:668-74.
104. Amarri S, Harding M, Coward WA, et al. 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 1997;76:349-51.
105. Vantrappen GR, Rutgeerts PJ, Ghoos YF, et al. Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology 1989;96:1126-34.
106. Ventrucci M, Cipolla A, Ubalducci GM, et al. 13C labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency. Gut 1998;42:81-7.
107. Strygler B, Nicar MJ, Santangelo WC, et al. Alpha 1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Gastroenterology 1990;99:1380-7.
108. Waldmann TA, Wochner RD, Strober W. The role of the gastrointestinal tract in plasma protein metabolism. Studies with 51Cr-albumin. Am J Med 1969;46:275-85.
109. Ohkohchi N, Himukai M, Igarashi Y, et al. Mechanism of D-xylose transport in human small intestine. J Pediatr Gastroenterol Nutr 1986;5:372-8.
110. Craig RM, Atkinson AJJ. D-xylose testing: a review. Gastroenterology 1988;95:223-31.
111. Craig RM, Ehrenpreis ED. D-xylose testing. J Clin Gastroenterol 1999;29:143-50.
112. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-81.
113. Ammann RW, Akovbiantz A, Largiader F, et al. Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology 1984;86:820-8.
114. Lankisch PG, Lohr-Happe A, Otto J, et al. Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion 1993;54:148-55.
115. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973;288:813-15.
116. Lankisch PG, Lembcke B, Wemken G, et al. Functional reserve capacity of the exocrine pancreas. Digestion 1986;35:175-81.
117. Go VL, DiMagno EP. Assessment of exocrine pancreatic function by duodenal intubation. Clin Gastroenterol 1984;13:701-15.
118. Lankisch PG. Function tests in the diagnosis of chronic pancreatitis. Critical evaluation. Int J Pancreatol 1993;14:9-20.
119. Waxman I, Steer ML, Freedman SD. Endoscopically assisted direct pancreatic function testing: a simplified technique. Gastrointest Endosc 1996;44:630.
120. Axon AT, Classen M, Cotton PB, et al. Pancreatography in chronic pancreatitis: international definitions. Gut 1984;25:1107-12.
121. Rolny P, Lukes PJ, Gamklou R, et al. A comparative evaluation of endoscopic retrograde pancreatography and secretin-CCK test in the diagnosis of pancreatic disease. Scand J Gastroenterol 1978;13:777-81.
122. Valentini M, Cavallini G, Vantini I, et al. A comparative evaluation of endoscopic retrograde cholangiopancreatography and the secretin-cholecystokinin test in the diagnosis of chronic pancreatitis: a multicentre study in 124 patients. Endoscopy 1981;13:64-7.
123. Lawson TL, Berland LL, Foley WD, et al. Ultrasonic visualization of the pancreatic duct. Radiology 1982;144:865-71.
124. Foley WD, Stewart ET, Lawson TL, et al. Computed tomography, ultrasonography, and endoscopic retrograde cholangiopancreatography in the diagnosis of pancreatic disease: a comparative study. Gastrointest Radiol 1980;5:29-35.
125. Luetmer PH, Stephens DH, Ward EM. Chronic pancreatitis: reassessment with current CT. Radiology 1989;171:353-7.
126. Sica GT, Braver J, Cooney MJ, et al. Comparison of endoscopic retrograde cholangiopancreatography with MR cholangiopancreatography in patients with pancreatitis. Radiology 1999;210:605-10.
127. Adamek HE, Albert J, Breer H, et al. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet 2000;356:190-3.
128. Robinson PJ, Sheridan MB. Pancreatitis: computed tomography and magnetic resonance imaging. Eur Radiol 2000;10:401-8.
129. Cappeliez O, Delhaye M, Deviere J, et al. Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 2000;215:358-64.
130. Manfredi R, Costamagna G, Brizi MG, et al. Severe chronic pancreatitis versus suspected pancreatic disease: dynamic MR cholangiopancreatography after secretin stimulation. Radiology 2000;214:849-55.
131. Sahai AV, Zimmerman M, Aabakken L, et al. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 1998;48:18-25.
132. Catalano MF, Lahoti S, Geenen JE, et al. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc 1998;48:11-17.
133. Wallace MB, Hawes RH. Endoscopic ultrasound in the evaluation and treatment of chronic pancreatitis. Pancreas 2001;23:26-35.
134. Ventrucci M, Gullo L, Daniele C, et al. Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease. Digestion 1983;28:114-21.
135. Jacobson DG, Curington C, Connery K, et al. Trypsin-like immunoreactivity as a test for pancreatic insufficiency. N Engl J Med 1984;310:1307-9.
136. Dominguez-Munoz JE, Pieramico O, Buchler M, et al. Ratios of different serum pancreatic enzymes in the diagnosis and staging of chronic pancreatitis. Digestion 1993;54:231-6.
137. Ventrucci M, Pezzilli R, Gullo L, Plate L, et al. Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. Dig Dis Sci 1989;34:39-45.
138. Durr HK, Otte M, Forell MM, et al. Fecal chymotroypsin: a study on its diagnostic value by comparison with the secretin-cholecystokinin test. Digestion 1978;17:404-9.
139. Ammann RW, Akovbiantz A, Hacki W, et al. Diagnostic value of the fecal chymotrypsin test in pancreatic insufficiency, particularly chronic pancreatitis: correlation with the pancreozymin-secretin test, fecal fat excretion and final clinical diagnosis. Digestion 1981;21:281-9.
140. Lankisch PG, Schreiber A, Otto J. Pancreolauryl test. Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function. Dig Dis Sci 1983;28:490-3.
141. Brown GA, Sule D, Williams J, et al. Faecal chymotrypsin: a reliable index of exocrine pancreatic function. Arch Dis Child 1988;63:785-9.
142. Lesi C, Melzi D'E, Scotta MS, et al. A new faecal chymotrypsin method for evaluating the exocrine pancreatic function in patients with different pancreatic diseases. Int J Pancreatol 1988;3:203-8.
143. Cavallini G, Benini L, Brocco G, et al. The fecal chymotrypsin photometric assay in the evaluation of exocrine pancreatic capacity. Comparison with other direct and indirect pancreatic function tests. Pancreas 1989;4:300-4.
144. Muench R, Ammann R. Fecal immunoreactive lipase: a new tubeless pancreatic function test. Scand J Gastroenterol 1992;27:289-94.
145. Glasbrenner B, Schön A, Klatt S, et al. Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis. Eur J Gastroenterol Hepatol 1996;8:1117-20.
146. Loser C, Mollgaard A, Folsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 1996;39:580-6.
147. Stein J, Jung M, Sziegoleit A, et al. Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem 1996;42:222-6.
148. Sziegoleit A, Knapler H, Peters B. ELISA for human pancreatic elastase 1. Clin Biochem 1989;22:79-83.
149. Amann ST, Bishop M, Curington C, et al. Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis. Pancreas 1996;13:226-30.
150. Masoero G, Zaffino C, Laudi C, et al. Fecal pancreatic elastase 1 in the work up of patients with chronic diarrhea. Int J Pancreatol 2000;28:175-9.
151. Lang C, Gyr K, Stalder GA, et al. Assessment of exocrine pancreatic function by oral administration of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (Bentiromide): 5 years' clinical experience. Br J Surg 1981;68:771-5.
152. Tanner AR, Fisher D, Ward C, et al. An evaluation of the one-day NBT-PABA/14C- PABA in the assessment of pancreatic exocrine insufficiency. Digestion 1984;29:42-6.
153. Mitchell CJ, Humphrey CS, Bullen AW, et al. The diagnostic value of the oral pancreatic function test. Scand J Gastroenterol 1979;14:183-7.
154. Dominguez-Munoz JE, Pieramico O, Buchler M, et al. Clinical utility of the serum pancreolauryl test in diagnosis and staging of chronic pancreatitis. Am J Gastroenterol 1993;88:1237-41.
155. Lankisch PG, Brauneis J, Otto J, et al. Pancreolauryl and NBT-PABA tests. Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency? Gastroenterology 1986;90:350-4.
156. Lock G, Kadow R, Messmann H, et al. Modified serum pancreolauryl test in chronic pancreatitis: evaluation in comparison to endoscopic retrograde pancreatography. Hepatogastroenterology 1997;44:1110-16.
157. Niederau C, Grendell JH. Diagnosis of chronic pancreatitis. Gastroenterology 1985;88:1973-95.
158. Lankisch PG, Schmidt I, Konig H, et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 1998;42:551-4.
159. Browning GG, Buchan KA, Mackay C. Clinical and laboratory study of postvagotomy diarrhoea. Gut 1974;15:644-53.
160. Bjorneklett A, Fausa O, Midtvedt T. Small-bowel bacterial overgrowth in the postgastrectomy syndrome. Scand J Gastroenterol 1983;18:277-87.
161. Bragelmann R, Armbrecht U, Rosemeyer D, et al. Small bowel bacterial overgrowth in patients after total gastrectomy. Eur J Clin Invest 1997;27:409-16.
162. Lewis SJ, Potts LF, Malhotra R, et al. Small bowel bacterial overgrowth in subjects living in residential care homes. Age Ageing 1999;28:181-5.
163. Riordan SM, McIver CJ, Wakefield D, et al. Small intestinal bacterial overgrowth in the symptomatic elderly. Am J Gastroenterol 1997;92:47-51.
164. Saltzman JR, Kowdley KV, Pedrosa MC, et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology 1994;106:615-23.
165. Lewis SJ, Franco S, Young G, O'Keefe SJ. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther 1996;10:557-61.
166. Hutchinson S, Logan R. The effect of long-term omeprazole on the glucose-hydrogen breath test in elderly patients. Age Ageing 1997;26:87-9.
167. Kitsch M. Bacterial overgrowth. Am J Gastroenterol 1990;85:231-7.
168. Corazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990;98:302-9.
169. Simon GL, Gorbach SL. The human intestinal microflora. Dig Dis Sci 1986;31:147S.
170. Hofmann AF, Fromm H. New breath test for bile acid deconjugation. N Engl J Med 1971;285:686-7.
171. Rhodes JM, Middleton P, Jewell DP. The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol 1979;14:333-6.
172. King CE, Toskes PP. Breath tests in the diagnosis of small intestine bacterial overgrowth. Crit Rev Clin Lab Sci 1984;21:269-81.
173. Bjorneklett A. Small bowel bacterial overgrowth syndrome. Scand J Gastroenterol Suppl 1983;85:83-93.
174. Thompson DG, O'Brien JD, Hardie JM. Influence of the oropharyngeal microflora on the measurement of exhaled breath hydrogen. Gastroenterology 1986;91:853-60.
175. Bond JH, Levitt MD. Use of breath hydrogen (H2) to quantitate small bowel transit time following partial gastrectomy. J Lab Clin Med 1977;90:30-6.
176. Saltzberg DM, Levine GM, Lubar C. Impact of age, sex, race, and functional complaints on hydrogen (H2) production. Dig Dis Sci 1988;33:308-13.
177. Riordan SM, McIver CJ, Walker BM, et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996;91:1795-803.
178. Caride VJ, Prokop EK, Troncale FJ, et al. Scintigraphic determination of small intestinal transit time: comparison with the hydrogen breath technique. Gastroenterology 1984;86:714-20.
179. Sellin JH, Hart R. Glucose malabsorption associated with rapid intestinal transit. Am J Gastroenterol 1992;87:584-9.
180. King CE, Toskes PP, Spivey JC, et al. Detection of small intestine bacterial overgrowth by means of a 14C-D-xylose breath test. Gastroenterology 1979;77:75-82.
181. King CE, Toskes PP. Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology 1986;91:1447-51.
182. Donald IP, Kitchingmam G, Donald F, et al. The diagnosis of small bowel bacterial overgrowth in elderly patients. J Am Geriatr Soc 1992;40:692-6.
183. Valdovinos MA, Camilleri M, Thomforde GM, et al. Reduced accuracy of 14C-D- xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol 1993;28:963-8.
184. Riordan SM, McIver CJ, Duncombe VM, et al. Factors influencing the 1-g 14C-D- xylose breath test for bacterial overgrowth. Am J Gastroenterol 1995;90:1455-60.
185. Stotzer PO, Kilander AF. Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion 2000;61:165-71.
186. Chang CS, Chen GH, Kao CH, et al. Increased accuracy of the carbon-14 D-xylose breath test in detecting small-intestinal bacterial overgrowth by correction with the gastric emptying rate. Eur J Nucl Med 1995;22:1118-22.
187. Lewis SJ, Young G, Mann M, et al. Improvement in specificity of [14C]d-xylose breath test for bacterial overgrowth. Dig Dis Sci 1997;42:1587-92.
188. Riordan SM, McIver CJ, Duncombe VM, et al. Bacteriologic analysis of mucosal biopsy specimens for detecting small-intestinal bacterial overgrowth. Scand J Gastroenterol 1995;30:681-5.
189. Stotzer PO, Brandberg A, Kilander AF. Diagnosis of small intestinal bacterial overgrowth in clinical praxis: a comparison of the culture of small bowel aspirate, duodenal biopsies and gastric aspirate. Hepatogastroenterology 1998;45:1018-22.
190. Attar A, Flourie B, Rambaud JC, et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 1999;117:794-7.
191. Schiller LR, Bilhartz LE, Santa A, et al. Comparison of endogenous and radiolabeled bile acid excretion in patients with idiopathic chronic diarrhea. Gastroenterology 1990;98:1036-43.
192. Eusufzai S, Axelson M, Angelin B, et al. Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test. Gut 1993;34:698-701.
193. Brydon WG, Nyhlin H, Eastwood MA, et al. Serum 7 alpha-hydroxy-4-cholesten-3- one and selenohomochotyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol 1996;8:117-23.
194. Nyhlin H, Merrick MV, Eastwood MA. Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT. Gut 1994;35:90-3.
195. Sciarretta G, Furno A, Mazzoni M, et al. Post-cholecystectomy diarrhea: evidence of bile acid malabsorption assessed by SeHCAT test. Am J Gastroenterol 1992;87:1852-4.
196. Niaz SK, Sandrasegaran K, Renny FH, et al. Postinfective diarrhoea and bile acid malabsorption. J R Coll Physicians Lond 1997;31:53-6.
197. Williams AJ, Merrick MV, Eastwood MA. Idiopathic bile acid malabsorption - a review of clinical presentation, diagnosis, and response to treatment. Gut 1991;32:1004-6.
198. Luman W, Williams AJ, Merrick MV, et al. Idiopathic bile acid malabsorption: long- term outcome. Eur J Gastroenterol Hepatol 1995;7:641-5.
199. Smith M, Cherian P, Raju G, et al. Bile acid malabsorption in persistent diarrhoea. J R Coll Physicans Lond 2000;34:448-51.
200. Brummer RJ, Karibe M, Stockbrugger RW. Lactose malabsorption. Optimalization of investigational methods. Scand J Gastroenterol Suppl 1993;200:65-9.
201. Sciarretta G, Furno A, Mazzoni M, et al. Lactulose hydrogen breath test in orocecal transit assessment. Critical evaluation by means of scintigraphic method. Dig Dis Sci 1994;39:1505-10.
202. Miller MA, Parkman HP, Urbain JL, et al. Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit. Dig Dis Sci 1997;42:10-18.
203. Saslow SB, Camilleri M. Diabetic diarrhea. Semin Gastrointest Dis 1995;6:187-93.
204. Buchanan KD, Johnston CF, Hare MM, et al. Neuroendocrine tumors. A European view. Am J Med 1986;81:14-22.
205. Eriksson B, Oberg K, Skogseid B. Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients. Acta Oncol 1989;28:373-7.
206. Guillausseau PJ, Guillausseau-Scholer C. Glucagonomas: clinical presentation, diagnosis and advances in management. In: Mignon M, Jensen RT, eds. Endocrine Tumours of the Pancreas: Recent Advances in Research and Management. Basel, Switzerland: S Karger, 1995.
207. Matuchansky C, Rambaud JC. VIPomas and endocrine cholera: Clinical presentation, diagnosis and advances in management. In: Mignon M, Jensen RT, eds. Endocrine Tumours of the Pancreas: Recent Advances in Research and Management. Basel, Switzerland: S. Karger, 1995.
208. Long RG, Bryant MG, Mitchell SJ, et al. Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas). BMJ (Clin Res Ed) 1981;282:1767-71.
209. Krejs GJ. VIPoma syndrome. Am J Med 1987;82:37-48.
210. Mekhjian HS, Dorisio TM. VIPoma syndrome. Semin Oncol 1987;14:282-91.
211. Ganguli PC, Cullen DR, Irvine WJ. Radioimmunoassay of plasma gastrin in pernicious anaemia, achlorhydria without pernicious anaemia, hypochlorhydria, and in controls. Lancet 1971;1:155-8.
212. Korman MG, Strickland RG, Hansky J. Serum gastrin in chronic gastritis. BMJ 1971;2:16-18.
213. Afzalpurkar RG, Schiller LR, Little KH, et al. The self-limited nature of chronic idiopathic diarrhea. N Engl J Med 1992;327:1849-52.